Burning Rock Biotech Ltd ADRBNR
Price$15.99Intrinsic value$13.6315% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $77.2M+9.2% YoYTTM through 31 Dec 2025
Net Income -$7.9MTTM through 31 Dec 2025
Free Cash Flow -$4.8MTTM through 31 Dec 2025

Margins

Current
Gross Margin74.7%
EBITDA Margin-6.1%
Operating Margin-10.2%
Net Margin-10.3%

Returns

-10.3%ROE
-6.7%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.99x
Net Debt-$476.5Mnet cash position
Cash & Equivalents$68.4M

Quality Metrics

Altman Z-Score-3.55
Piotroski F-Score6 / 9
FCF Margin-6.2%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $539.6M
Diluted EPS
'20'21
FY2021: $0.00

Dividend

No dividend

Capital Allocation

R&D Spend$23.8M
Capex Intensity1.0%
Financials converted at 6.9961 from RMB.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.